This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2015-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Eagleville, PA (US) (2015)
- Oreland, PA (US) (2021)
Company Filing History:
Years Active: 2015-2021
Title: The Innovative Mind of Kristen G Jones
Introduction: Kristen G Jones is a distinguished inventor based in Oreland, Pennsylvania, recognized for her significant contributions to the field of pharmaceutical innovations. With a robust portfolio of two patents, her work primarily focuses on the development of compounds that hold promise for treating critical diseases, including cancer and neurodegenerative disorders.
Latest Patents: Kristen's latest patents are groundbreaking in their respective fields. The first patent revolves around "3-aryl-heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (HDAC6) inhibitors." This invention is directed to substituted 5-trifluoromethyl oxadiazole compounds, specifically mentioned within a unique generic formula. These compounds may prove vital in treating cellular proliferative diseases, such as cancer and conditions like schizophrenia and stroke.
Her second patent, titled "TrkA kinase inhibitors, compositions and methods thereof," involves benzyl urea compounds that serve as inhibitors for the tropomyosin-related kinase (Trk) family of protein kinases. The applications of this invention span across various medical concerns, including pain, inflammation, cancer, and a range of disorders tied to nerve growth factor receptors.
Career Highlights: Kristen is currently associated with Merck Sharp & Dohme Corporation, a leader in the pharmaceutical industry. Her role at the company highlights her dedication and the impact of her research on global health initiatives.
Collaborations: Kristen has collaborated with talented individuals, including her coworkers Shawn J Stachel and Melissa S Egbertson. Their combined efforts in research and development continue to cultivate innovations in therapeutic options.
Conclusion: Kristen G Jones exemplifies the spirit of innovation within the pharmaceutical field. Her patents not only reflect her dedication as an inventor but also represent advancements that can lead to significant improvements in medical treatment. The results of her work underscore the importance of continued research and collaboration in the pursuit of better health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile